Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Sales | 348 | 350 | 298 | 365 | 305 |
| Cost of Goods | 329 | 95 | 438 | 147 | 127 |
| Gross Profit | 19 | 255 | -140 | 217 | 177 |
| Operating Expenses | 2,652 | 1,865 | 2,573 | 2,235 | 2,314 |
| Operating Income | -2,304 | -1,515 | -2,274 | -1,871 | -2,009 |
| Interest Expense | 68 | 44 | 29 | 4 | 1 |
| Other Income | -1 | 0 | -603 | -1 | 0 |
| Pre-tax Income | -2,373 | -1,559 | -2,906 | -1,875 | -2,010 |
| Net Income Continuous | -2,373 | -1,559 | -2,173 | -1,875 | -2,010 |
| Net Income | $-2,373 | $-1,559 | $-2,173 | $-1,875 | $-2,010 |
| EPS Basic Total Ops | -7,552.46 | -4,945.07 | -6,941.07 | -6,113.90 | -6,653.36 |
| EPS Basic Continuous Ops | -7,509.38 | -4,946.06 | -6,916.95 | -6,037.68 | -6,684.16 |
| EPS Diluted Total Ops | -7,552.46 | -4,945.07 | -6,941.07 | -6,113.90 | -6,653.36 |
| EPS Diluted Continuous Ops | -7,509.38 | -4,946.06 | -6,916.95 | -6,037.68 | -6,684.16 |
| EBITDA(a) | $-2,284 | $-1,495 | $-2,259 | $-1,866 | $-2,005 |